arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

NEPHROS INC

NEPH
$4.27 ▲ +0.08 (+1.91%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
66 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Neutral
auto_awesome

Analytical Summary

NEPHROS INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $46.4M
Dividend Yield
Revenue Growth 36.2%
Op. Margin 20.2%
ROIC None
FCF / Share $0.06
Trailing P/E 38.8x
Price / Book
FCF Yield 1.5%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$6.02M
↑ +36.2%
Net Income Profit after all expenses
$140.00K
↓ -74.9%
Operating Margin Operating profit as % of sales
20.2%
↑ +983.2% 46th
FCF / Share Free cash flow per share
$0.06
↑ +140.0%
Long-Term Debt Long-term obligations
$141.00K
↓ -32.9%

Health Breakdown

Profitability
52
Financial Health
99
Cash Quality
78

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 66 quarters